Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLONICEL in children and adolescents with ADHD
NCT00556959Phase 3Completed
- Sponsor
- Addrenex Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Addrenex Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00556959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556959.